Balance Sheet
Accumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current Deffered RevenueNotes PayablesOther Accumulated ExpensesPayablesPreferred Stock LiabilitiesPrepaid AssetsReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

GP-Act III Acquisition (GPAT) Accumulated Expenses (2024 - 2025)

GP-Act III Acquisition (GPAT) has disclosed Accumulated Expenses for 2 consecutive years, with $233299.0 as the latest value for Q4 2025.

  • Quarterly Accumulated Expenses rose 0.73% to $233299.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $233299.0 through Dec 2025, up 0.73% year-over-year, with the annual reading at $233299.0 for FY2025, 0.73% up from the prior year.
  • Accumulated Expenses for Q4 2025 was $233299.0 at GP-Act III Acquisition, up from $211263.0 in the prior quarter.
  • The five-year high for Accumulated Expenses was $293581.0 in Q1 2025, with the low at $17680.0 in Q1 2024.